Milton Essex S.A.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-03-24
Share capital
7,511,202.60 PLN
Activity description

Milton Essex is a med-tech company specializing in allergy diagnostics, offering products such as the SkinSENS™ system and the Allergoscope program. The company conducts research utilizing artificial intelligence, optoelectronics, and thermodynamics to develop innovative medical systems. Additionally, it focuses on creating new medical procedures and strong partnerships to revolutionize healthcare.

Registered address
ul. Żołny 42A, 02-815 Warszawa, Poland
Email
Phone

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Istnieją okoliczności wskazujące na zagrożenie kontynuowania działalności z uwagi na fakt długotrwale utrzymującej się straty oraz ze względu na brak płynności finansowej.

Filing timeliness

5 of 6 financial statements were filed late (the longest delay 155 days for 2023). All were audited by a statutory auditor.

  • 202515/07/2026
  • 202421/10/2025
  • 202317/12/2024
  • 202220/10/2023
  • 202104/10/2022
  • 202005/11/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.35
-0.04 (-10.71%)
0.320.340.360.380.3510:0012:0014:0016:00
Open
PLN 0.39
High
PLN 0.39
Low
PLN 0.32
Volume
218.71K
Avg. vol.
71.75K
Market cap
PLN 26.29M
P/E ratio
–
EPS
-PLN 0.02
Shares outstanding
75.11M
52-week
PLN 0.32 – 0.47
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 0.00USD -4.18–
Q1 2026USD 0.00USD -10.98–
Q4 2025USD 0.00––

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Other manufacturing367 / 493
Top 74%
Sector · Manufacturing9,740 / 11,963
Top 81%
City · Warszawa42,052 / 56,729
Top 74%
Voivodeship · Mazowieckie58,174 / 76,892
Top 76%
Country · Poland229,433 / 297,069
Top 77%

Results vs industry

Revenue
This companyUSD 40.86kMedianUSD 287.80kAverageUSD 4.92m
Net profit
This companyUSD -167.21kMedianUSD 10.65kAverageUSD 206.72k
Operating costs
This companyUSD 192.45kMedianUSD 269.05kAverageUSD 4.50m
Assets
This companyUSD 12.90mMedianUSD 221.07kAverageUSD 5.78m

Offer

  • Allergy diagnostic system
  • Allergic skin tests
  • Multispectral imaging system
  • Temperature measurement device
  • Skin imaging device

Websites

  • miltonessex.euMILTON ESSEX – diagnostyka alergii i med-tech AI
    WordPress 7.1Yoast SEOLiteSpeed

Trademarks

The company holds 4 active trademarks registered with the Polish Patent Office. 4 marks have expired or were not registered. The first mark was filed in 2014.

MarkNumberClassesStatusProtected until
SkinSense Z.51762610Protected Aug 28, 2030
FACE-COV Z.51495310, 42Protected Jun 19, 2030
InfraSkin Z.49410110, 42, 44Protected Dec 20, 2028
S InfraScan Z.49277010, 42, 44Protected Nov 16, 2028
SkinSensic Z.58288110Not registered –
MarkProtected until
SkinSense Aug 28, 2030
FACE-COV Jun 19, 2030
InfraSkin Dec 20, 2028
S InfraScan Nov 16, 2028
SkinSensic –

Authorized Representatives

Jacek Bernard Stępień age 63 – President of the Management Board
Joanna Sanford age 59 – Vice President of the Management Board

Manner of representation

President of the Management Board acting independently, or two members of the management board acting jointly.

Supervisory board

Adam Andrzej Starczewski age 52 – Supervisory Board Member
Marcin Ireneusz Brendota age 52 – Supervisory Board Member
Paweł Jerzy Łukasiewicz age 53 – Supervisory Board Member
Stanisław Józef Kłosowicz age 71 – Supervisory Board Member
Maciej Kaliński age 52 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
Sanford Biotech sp. z o.o.
100%
100%

Bank accounts

Registered as a VAT taxpayer on 2015-09-22.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 2,891

MSiG notices

Publication dateEvent
Nov 17, 2025List of claims
Jun 30, 2020Shareholders' meeting convened

Public aid

11 public aid cases recorded, with a total value of $4,712,432.

PurposeGross amount
Aid for research and development projects: industrial research
$1.2M
Aid for research and development projects: experimental development
$528.8K
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,653

European Funds

ProjectEU co-financing
FACE-COV™ – a system solution for automated monitoring of public places using thermographic imaging and detection of SARS-COV2 infection markers with artificial intelligence, including a biometric identification option (digital tagging), meeting medical device standards.
$1.8M
Obtaining international patent protection for 1 invention in the MedTech field.
$54,395
FIRIMAS – A solution for functional imaging of cutaneous allergic responses in the infrared
$918.6K

Competitors

Name
Oasis Diagnostics S.A.
Envcheck sp. z o.o.
Invinets sp. z o.o.
Irtsys sp. z o.o.
Radialtec Poland sp. z o.o.
Instella sp. z o.o.
Smart Labs sp. z o.o.
Insway Technology sp. z o.o.
Grupa Psychotronics sp. z o.o.
Smartmedics sp. z o.o.

Change history

DateEvent
2026-06-12Share capital increase
2024-04-16Address change
2020-08-05Share capital increase
2019-06-14Share capital increase
2018-04-25Share capital increase

FAQ

Last updated: 2026-07-30